|
|
7E F Stange
![]() Summary for 2004 [at-glance overview of E F Stange work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author E F Stange. According to available data, in 2004 E F Stange published at least 7 articles. This work was completed in collaboration with several authors including Herrlinger, K and Fellermann, K. Many other authors have collaborated with E F Stange as well. There is no information about the funding or the grants awarded to support this work.
E F Stange has rank 40 when compared to all other authors using the keyword Crohn Disease. Analysis of the article abstracts and the titles suggests that E F Stange professional interests are focused around "patients nod2 mutations", "mutations crohn disease" and "inflammatory bowel diseases". These might also be referred to as "crohn disease", "nod2 mutations" or "hd-5 hd-6". Statistical analysis shows that E F Stange's writing is likely to contains terms "disease", "nod2", "crohn", "expression", "mutations" and "mucosal".
Unfortunately, there is not enough information to establish E F Stange affiliation. Luckily, several email addresses are on file. Images [images we found on the Internet for E F Stange]loading...
Do you know E F Stange who matches the profile above? Click the photo and let us know!
Alternative names (1) [other authors with names similar to E F Stange]Year 2004 Charts [E F Stange frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of E F Stange publication and funding history for the range of years]Emails (2) [email addresses extracted from E F Stange affiliations]hidden to prevent spam, click here to reveal E F Stange Coauthors (46) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (6) [condensed summary of the E F Stange affiliations, the leading number and the color conveys importance]- 1Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany.
1Abteilung Innere Medizin 1, Zentrum für Innere Medizin, Robert-Bosch-Krankenhaus, Stuttgart. 1Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie, Charité, Universitätsmedizin Berlin. 1Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin, Stuttgart. 1Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. 1Abteilung Innere Medizin I, Robert-Bosch-Krankenhaus, Stuttgart.
Key Opinion Leader In [E F Stange is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 40Crohn Disease | 60Colitis, Ulcerative | 76Remission Induction
Keywords (32) [keywords assigned to E F Stange articles by PubMed, the leading number and the color conveys importance]- 7Humans | 4Crohn Disease | 4Adult | 3Colitis, Ulcerative | 3Female | 3Remission Induction | 2Adolescent | 2Pouchitis | 2Diagnosis, Differential | 2Inflammatory Bowel Diseases | 2Anti-Bacterial Agents | 2Recurrence | 2Controlled Clinical Trials as Topic | 2Gene Expression Regulation | 2Risk Factors | 2Immunity, Mucosal | 2Middle Aged | 2Male | 1Colon | 1Interleukin-8 | 1Intestines | 1alpha-Defensins | 1Defensins | 1Primary Prevention | 1Thionucleotides | 1Tumor Necrosis Factor-alpha | 1Immunosuppressive Agents | 1Tacrolimus | 1Nod2 Signaling Adaptor Protein | 1Azathioprine | 1RNA, Messenger | 1Magnetic Resonance Imaging
E F Stange Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; E F Stange might be a good expert witness on these terms]- 15disease | 14nod2 | 12crohn | 8expression | 8mutations | 8mucosal | 7defensins | 5patients | 5response | 5hd-5 | 5paneth | 5bowel | 56-thioguanine-nucleotide | 5levels | 5diminished | 4inflammatory | 4bacterial | 4diseases | 4hd-6 | 4barrier | 4ileum | 4human | 4defensin | 4pathogenesis | 3cells | 3colitis | 3tioguanine | 3lysozyme | 3intestinal | 3wild-type | 3spla2 | 3activity
- 11crohn disease | 5nod2 mutations | 4hd-5 hd-6 | 3patients nod2 | 3inflammatory bowel | 3paneth cells | 3mutations crohn | 3bowel disease | 2mucosal barrier | 2bowel diseases | 26-thioguanine-nucleotide levels | 2may explain | 2methylated 6-thioguanine-nucleotide | 2hd-6 spla2 | 2defensin expression | 2ulcerative colitis | 2wild-type nod2 | 2mutations wild-type | 2expression may | 2card15 mutations | 2nod2 card15 | 2role defensins | 2associated diminished | 2disease associated | 2thioguanine-nucleotides predict | 2alpha-defensin expression | 2alpha defensins | 2pathogenesis chronic-inflammatory | 2predict efficacy | 2diminished mucosal | 2mutations nod2 | 2mucosal alpha-defensin
- 3patients nod2 mutations | 3mutations crohn disease | 2inflammatory bowel diseases | 2hd-5 hd-6 spla2 | 2nod2 mutations wild-type | 2expression may explain | 2nod2 card15 mutations | 2mucosal alpha-defensin expression | 2efficacy tioguanine crohn | 2defensins pathogenesis chronic-inflammatory | 2chronic-inflammatory bowel disease | 2predict efficacy tioguanine | 2disease associated diminished | 2crohn disease associated | 2tioguanine crohn disease | 2thioguanine-nucleotides predict efficacy | 2associated diminished mucosal | 2card15 mutations crohn | 2role defensins pathogenesis | 2pathogenesis chronic-inflammatory bowel | 2diminished mucosal alpha-defensin | 1thioguanine-nucleotide levels paradigm | 1associated nod2 mutation | 1nucleotide levels patients | 1experienced bone marrow | 1based consensus conference | 1tioguanine therapy related | 1patients immunohistochemistry identified | 1results evidence based | 1protozoa giardia lamblia | 1mucosal adherent invasive | 1crohn disease especially
Reader's Comments (0) [comments posted by readers of E F Stange profile]Funding (0) [selected NIH grants to E F Stange and the award amounts for recent years]- award information is not available
E F Stange Articles (7) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. (2004) >> Department of Internal Medicine I, Robert Bosch Hospital, Stuttgart, Germany. 5Stallmach, A, 2Wehkamp, J, 1Schlee, M, 1Fritz, P, 1Bevins, C L, 7Stange, E F, 4Noack, F, 1Schäffeler, E, 2Herrlinger, K R, 3Schwab, M, 3Harder, J, 6Schröder, J M, 3Fellermann, K, 2Weichenthal, M.[Chronic inflammatory bowel diseases] (2004) >> Abteilung Innere Medizin 1, Zentrum für Innere Medizin, Robert-Bosch-Krankenhaus, Stuttgart. 7Stange, E F, 5Herrlinger, K.[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease] (2004) >> Medizinische Klinik I mit Schwerpunkt Gastroenterologie/Infektiologie/Rheumatologie, Charité, Universitätsmedizin Berlin. 7Wittekind, C, 1Riemann, J, 5Bischoff, S C, 4Pox, C, 1Kroesen, A J, 5Hoffmann, J C, 8Schwandner, O, 9Schmiegel, W, 6Reinshagen, M, 11Fölsch, U R, 1Kaltz, B, 2Selbmann, H K, 5Buhr, H J, 6Moser, G, 4Fleig, W, 5Herrlinger, K, 2Knebel, U, 17Zeitz, M, 6Kruis, W, 9Rogler, G, 1Keller, K M, 6Fischer, I, 3Jantschek, G, 33Schölmerich, J, 2Brambs, H J, 7Stange, E F, 4Dignass, A, 2Höhne, W, 1Mundt, S, 3Reissmann, A, 14Schreiber, S, 3Matthes, H, 4Bruch, H P, 2Utzig, M.[Pouchitis] (2004) >> Robert-Bosch-Krankenhaus, Zentrum für Innere Medizin, Stuttgart. 7Stange, E F, 2Buhr, H-J.Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease. (2004) >> Department of Gastroenterology, Hepatology and Endocrinology, Robert-Bosch-Hospital, Stuttgart, Germany. 2Schoelmerich, J, 4Rühl, A, 2Herrlinger, K R, 12Fleig, W E, 6Reinshagen, M, 3Schwab, M, 8Fischer, C, 3Fellermann, K, 2Kreisel, W, 4Deibert, P, 7Stange, E F, 1Greinwald, R.[The role of defensins in the pathogenesis of chronic-inflammatory bowel disease] (2004) >> Abteilung Innere Medizin I, Robert-Bosch-Krankenhaus, Stuttgart. 12Schmid, M, 2Wehkamp, J, 3Fellermann, K, 7Stange, E F, 5Herrlinger, K.[Another paradigm shift: defective innate--not specific--immune system in Crohn's disease?] (2004) >> 7Stange, E F.
Science Trivia (2) [Interactive math & science trivia questions]
|
|